Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment

F1000Res. 2021 Mar 18:10:221. doi: 10.12688/f1000research.51066.3. eCollection 2021.

Abstract

Prostate cancer (CaP) is one of the leading causes of death in men worldwide. Much attention has been given on its prevention and treatment strategies, including targeting the regulation of 5-alpha-Reductase (5αR) enzyme activity, aimed to limit the progression of CaP by inhibiting the conversion of potent androgen dihydrotestosterone from testosterone that is thought to play a role in pathogenesis of CaP, by using the 5-alpha-Reductase inhibitors (5αRis) such as finasteride and dutasteride. However, 5αRis are reported to exhibit numerous adverse side effects, for instance erectile dysfunction, ejaculatory dysfunction and loss of libido. This has led to a surge of interest on plant-derived alternatives that might offer favourable side effects and less toxic profiles. Phytochemicals from plants are shown to exhibit numerous medicinal properties in various studies targeting many major illnesses including CaP. Therefore, in this review, we aim to discuss the use of phytochemicals namely phytosterols, polyphenols and fatty acids, found in various plants with proven anti-CaP properties, as an alternative herbal CaP medicines as well as to outline their inhibitory activities on 5αRs isozymes based on their structural similarities with current 5αRis as part of CaP treatment approaches.

Keywords: 5-alpha-reductase; Androgens; Dihydrotestosterone; Dutasteride; Finasteride; Phytochemicals; Phytosterols; Polyphenols; Prostate cancer; Testosterone.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cholestenone 5 alpha-Reductase*
  • Humans
  • Male
  • Oxidoreductases
  • Phytochemicals / therapeutic use
  • Prospective Studies
  • Prostatic Neoplasms* / drug therapy

Substances

  • Phytochemicals
  • Oxidoreductases
  • Cholestenone 5 alpha-Reductase